The efficacy of pioglitazone compared to metformin in drug naive patients with type 2 diabetes

被引：0
|
作者：
Schernthaner, G
Edwards, G
Lee, C
Tan, M
Herz, M
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A455 / A455
页数：1
相关论文
共 50 条
  • [1] The efficacy of pioglitazone compared to metformin in drug naive patients with Type 2 diabetes.
    Lenton, S
    Schernthaner, G
    Edwards, G
    Lee, C
    Tan, M
    Herz, M
    [J]. DIABETOLOGIA, 2003, 46 : A287 - A287
  • [2] Tolerability of pioglitazone compared to metformin in patients with Type 2 diabetes mellitus.
    Herz, M
    Tan, MH
    Pavo, I
    Melnichenko, GA
    Shoustov, SB
    Gyimesi, A
    Varkonyi, T
    Johns, D
    Schluchter, BJ
    Widel, M
    [J]. DIABETOLOGIA, 2002, 45 : A251 - A252
  • [3] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin versus pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Liu, G.
    Lee, M. A.
    Sisk, C. McCrary
    Williams-Herman, D. E.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETOLOGIA, 2010, 53
  • [4] Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients with Type 2 Diabetes
    Cuddihy, Robert M.
    Russell-Jones, David
    Hanefeld, Markolf
    Kumar, Ajay
    Gonzalez, Jose G.
    de Teresa, Luis
    Boardman, Marilyn
    Chan, Melanie
    Wolka, Anne M.
    Porter, Lisa
    [J]. DIABETES, 2011, 60 : A77 - A77
  • [5] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Lee, M. A.
    Sisk, C. M.
    Williams-Herman, D. E.
    Engel, S. S.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (09) : 930 - 938
  • [6] Efficacy of additional pioglitazone administration on to metformin in inadequately controlled patients with type 2 diabetes
    Kawai, Toshihide
    Funae, Osamu
    Shimada, Akira
    Hirata, Takumi
    Tabata, Mitsuhisa
    Atsumi, Yoshihito
    Itoh, Hiroshi
    [J]. DIABETES, 2007, 56 : A545 - A545
  • [7] Pioglitazone Compared with Metformin Increases Pericardial Fat Volume in Patients with Type 2 Diabetes Mellitus
    Jonker, J. T.
    Lamb, H. J.
    van der Meer, R. W.
    Rijzewijk, L. J.
    Menting, L. J.
    Diamant, M.
    Bax, J. J.
    de Roos, A.
    Romijn, J. A.
    Smit, J. W. A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01): : 456 - 460
  • [8] The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus
    Erdem, Gokhan
    Dogru, Teoman
    Tasci, Ilker
    Bozoglu, Ergun
    Muhsiroglu, Ozlem
    Tapan, Serkan
    Ercin, Cemal Nuri
    Sonmez, Alper
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (02) : 214 - 218
  • [9] Combination therapy with pioglitazone and metformin in patients with type 2 diabetes
    Egan, J
    Rubin, C
    Mathisen, A
    [J]. DIABETES, 1999, 48 : A117 - A117
  • [10] Efficacy of vildagliptin in drug-naive patients with type 2 diabetes
    Dejager, S.
    Baron, M. A.
    Razac, S.
    Foley, J. E.
    Dickinson, S.
    Schweizer, A.
    [J]. DIABETOLOGIA, 2006, 49 : 479 - 480
12345